Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-19
1990-09-04
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540472, 540500, 544 586, 544127, 544128, 544349, 544362, 544363, 546123, 546156, A61K 31435, C07D47104
Patent
active
049545078
ABSTRACT:
There are disclosed new naphthyridine- and quinoline-carboxylic acids having a 1-tertiary-alkyl substituent, compositions containing them, and their use in treating bacterial infections in warm-blooded animals. Also disclosed are novel amines and intermediates used in the preparation of the naphthyridine- and quinoline-carboxylic acids.
REFERENCES:
patent: 3590036 (1971-06-01), Lesher et al.
patent: 4341784 (1982-07-01), Matsumoto et al.
Egawa et al., J. Med. Chem., 27, pp. 1543-1548, (1984).
Bouzard Daniel
Di Cesare Pierre
Essiz Munir
Jacquet Jean-Pierre
Remuzon Philippe
Algieri Aldo A.
Bristol-Myers Company
Carnahan Robert E.
Dentz Bernard I.
Ford John M.
LandOfFree
1-tertiary-alkyl-substituted naphthyridine carboxylic acid antib does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antib will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442283